Canada
About Dako
When a person is confronted with a possible cancer diagnosis, a biopsy is performed and tissue is taken out. The tissue is tested in a pathology lab and a report is generated. The report confirms or rules out a cancer diagnosis and determines the ‘stages’ or to what extent the cancer has spread. Treatment options are found by information on the size, shape and appearance of the tissue under a microscope. Dako provides the antibodies; reagents and instruments enabling physicians choose the right form of treatment, the first time.
We are helping doctors help their patients.
News
Van Andel Research Institute and Dako sign agreement to license cancer diagnostic tool
May 17, 2012
-
Dako enters into new collaboration with Genentech on FDA regulatory submissions
May 01, 2012
-
Dako Pathology Catalog 2012
Mar 02, 2012
-
Dako Enters into an Additional Collaboration with Amgen
Feb 20, 2012
Press Information
Legal Information
Annual Report 2010
It's all about cancer!
We fight cancer by providing high quality antibodies, instruments and software. We are raising the global standards for fast and accurate diagnostic answers for cancer patients.